MARKER THERAPEUTICS, INC.: cashflow_financing
| Value | {"amount": 1372192, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2012-01-02 – 2012-12-31 |
| Status | current |
| Entity | MARKER THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:54:30.727303+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/aadefa6b-e115-424b-af3f-ff07d481f2ff
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001424884-14-000048Retrieved: 2026-08-19T10:54:30.727303+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001094038/cashflow-financing/2012-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/aadefa6b-e115-424b-af3f-ff07d481f2ff
History
- no predecessors — first report